Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Urology|August 1, 2020
Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrenceJustin Ferdinandus, Wolfgang Peter Fendler, Boris Hadaschik, et al.
Seminars in Hematology|July 8, 2023
Clinical applications of circulating tumor DNA in Hodgkin lymphomaJan-Michel Heger, Justin Ferdinandus, Julia Mattlener, et al.
Current Opinion in Urology|December 27, 2017
Prostate-specific membrane antigen theranostics: therapy with lutetium-177Justin Ferdinandus, John Violet, Shahneen Sandhu, et al.
European Journal of Radiology|August 14, 2021
Theranostics in oncology: What radiologists want to knowJustin Ferdinandus, Wolfgang Peter Fendler, Joshua James Morigi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 30, 2020
Managing patient flows in radiation oncology during the COVID-19 pandemic : Reworking existing treatment designs to prevent infections at a German hot spot area University HospitalDennis Akuamoa-Boateng, Simone Wegen, Justin Ferdinandus, et al.
Nuclear Medicine and Biology|April 18, 2021
Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancerMagdalena Staniszewska, Janette Iking, Katharina Lückerath, et al.
European Urology Focus|January 23, 2021
Prostate-specific Membrane Antigen-based Imaging of Castration-resistant Prostate CancerManuel Weber, Boris Hadaschik, Justin Ferdinandus, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2026
Patient Perspective on Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Advanced-Stage Classic Hodgkin Lymphoma Treated With Multiagent Chemotherapy Regimens in the HD21 TrialFjoralba Kristo, Flora Mazerolle, Thibaud Alin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2023
Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study GroupJustin Ferdinandus, Lutz van Heek, Katrin Roth, et al.
Seminars in Nuclear Medicine|May 27, 2022
A Role for PET/CT in Response Assessment of Malignant Pleural MesotheliomaPatrick Sandach, Robert Seifert, Wolfgang P Fendler, et al.
Pageof 5